Trans-fatty acids and cancer: A mini-review

British Journal of Nutrition

Volumn 102, Issue 9, 2009, Pages 1254-1266

  Smith, Brennan K ^a   Robinson, Lindsay E ^a   Nam, Robert ^b   Ma, David W L ^a  

^a UNIVERSITY OF GUELPH   (Canada)

^b SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

Cancer; Elaidic acid; Trans fatty acids; Vaccenic acid

Indexed keywords

CYTOKINE; OMEGA 3 FATTY ACID; TRANS FATTY ACID; TRANSCRIPTION FACTOR;

ADIPOSE TISSUE; BREAST CANCER; CALORIC INTAKE; CANCER RISK; CARCINOGENESIS; COLON CANCER; DIETARY INTAKE; ENVIRONMENTAL FACTOR; EXPERIMENTAL MODEL; GENETIC POLYMORPHISM; HEALTH HAZARD; HUMAN; INFLAMMATION; ISOMER; LIFESTYLE; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; OXIDATIVE STRESS; PROSTATE CANCER; REVIEW; ANIMAL; BREAST TUMOR; CELL TRANSFORMATION; CHEMICALLY INDUCED DISORDER; COLON TUMOR; DISEASE MODEL; DRUG EFFECT; FEMALE; MALE; MOUSE; NEOPLASM; PROSTATE TUMOR; RAT;

ANIMALIA;

ANIMALS; BREAST NEOPLASMS; CELL TRANSFORMATION, NEOPLASTIC; COLONIC NEOPLASMS; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; MALE; MICE; NEOPLASMS; PROSTATIC NEOPLASMS; RATS; TRANS FATTY ACIDS;

EID: 73349135035     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114509991437     Document Type: Review

References (112)

1. Zaloga GP, Harvey KA, Stillwell W, et al. (2006) Trans fatty acids and coronary heart disease. Nutr Clin Pract 21, 505-512.
2. Ascherio A (2006) Trans fatty acids and blood lipids. Atheroscler Suppl 7, 25-27.
3. Canadian Cancer Society & National Cancer Institute of Canada (2008) Canadian Cancer Statistics 2008. Toronto, Canada. http://www.cancer.ca/canada- wide/about%20cancer/ cancer%20statistics//media/CCS/Canada%20wide/Files%20 List/English%20files%20heading/pdf%20not%20in%20 publications%20section/ Canadian%20Cancer%20Society%20 Statistics%20PDF%202008-614137951.ashx
4. Jemal A, Siegel R, Ward E, et al. (2008) Cancer statistics, 2008. CA Cancer J Clin 58, 71-96.
5. Chavarro JE, Stampfer MJ, Campos H, et al. (2008) A prospective study of trans-fatty acid levels in blood and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 17, 95-101.
6. Liu X, Schumacher FR, Plummer SJ, et al. (2007) Trans-fatty acid intake and increased risk of advanced prostate cancer: modification by RNASEL R462Q variant. Carcinogenesis 28, 1232-1236.
7. Mozaffarian D (2008) Commentary: ruminant trans fatty acids and coronary heart disease - cause for concern? Int J Epidemiol 37, 182-184.
8. Jakobsen MU, Overvad K, Dyerberg J, et al. (2008) Intake of ruminant trans fatty acids and risk of coronary heart disease. Int J Epidemiol 37, 173-182.
9. Martin CA, Milinsk MC, Visentainer JV, et al. (2007) Trans fatty acid-forming processes in foods: a review. An Acad Bras Cienc 79, 343-350.
10. Allison DB, Egan SK, Barraj LM, et al. (1999) Estimated intakes of trans fatty and other fatty acids in the US population. J Am Diet Assoc 99, 166-174.
11. Thompson AK, Shaw DI, Minihane AM, et al. (2008) Transfatty acids and cancer: the evidence reviewed. Nutr Res Rev 21, 174-188.
12. Health Canada & the Heart and Stroke Foundation of Canada (2006) TRANSforming the Food Supply. Report of the Trans Fat Task Force. http://www.hc-sc.gc.ca/fn-an/nutrition/ gras-trans-fats/tf-ge/tf-gt-rep-rap-eng. php
13. Gebauer SK, Psota TL & Kris-Etherton PM (2007) The diversity of health effects of individual trans fatty acid isomers. Lipids 42, 787-799.
14. Aro A & Salminen I (1998) Difference between animal and vegetable trans fatty acids. Am J Clin Nutr 68, 918-919.
15. Kraft J, Collomb M, Mockel P, et al. (2003) Differences in CLA isomer distribution of cow's milk lipids. Lipids 38, 657-664.
16. Micha R & Mozaffarian D (2008) Trans fatty acids: effects on cardiometabolic health and implications for policy. Prostaglandins Leukot Essent Fatty Acids 79, 147-152.
17. Oomen CM, Ocke MC, Feskens EJ, et al. (2001) Association between trans fatty acid intake and 10-year risk of coronary heart disease in the Zutphen Elderly Study: a prospective population-based study. Lancet 357, 746-751.
18. Willett WC, Stampfer MJ, Manson JE, et al. (1993) Intake of trans fatty acids and risk of coronary heart disease among women. Lancet 341, 581-585.
19. Jakobsen MU, Overvad K, Dyerberg J, et al. (2008) Intake of ruminant trans fatty acids and risk of coronary heart disease. Int J Epidemiol 37, 173-182.
20. Awad AB (1981) Trans fatty acids in tumor development and the host survival. J Natl Cancer Inst 67, 189-192.
21. Ip C & Marshall JR (1996) Trans fatty acids and cancer. Nutr Rev 54, 138-145.
22. Hogan ML & Shamsuddin AM (1984) Large intestinal carcinogenesis. I. Promotional effect of dietary fatty acid isomers in the rat model. J Natl Cancer Inst 73, 1293-1296.
23. Selenskas SL, Ip MM & Ip C (1984) Similarity between trans fat and saturated fat in the modification of rat mammary carcinogenesis. Cancer Res 44, 1321-1326.
24. Reddy BS, Tanaka T & Simi B (1985) Effect of different levels of dietary trans fat or corn oil on azoxymethane-induced colon carcinogenesis in F344 rats. J Natl Cancer Inst 75, 791-798. (Pubitemid 16222409)
25. Hopkins GJ & Carroll KK (1979) Relationship between amount and type of dietary fat in promotion of mammary carcinogenesis induced by 7,12-dimethylbenz[a]anthracene. J Natl Cancer Inst 62, 1009-1012.
26. Sugano M, Watanabe M, Yoshida K, et al. (1989) Influence of dietary cis and trans fats on DMH-induced colon tumors, steroid excretion, and eicosanoid production in rats prone to colon cancer. Nutr Cancer 12, 177-187.
27. Watanabe M, Koga T & Sugano M (1985) Influence of dietary cis- and trans-fat on 1,2-dimethylhydrazine-induced colon tumors and fecal steroid excretion in Fischer 344 rats. Am J Clin Nutr 42, 475-484.
28. Cassagno N, Palos-Pinto A, Costet P, et al. (2005) Low amounts of trans 18 : 1 fatty acids elevate plasma triacylglycerols but not cholesterol and alter the cellular defence to oxidative stress in mice. Br J Nutr 94, 346-352.
29. Banni S, Angioni E, Murru E, et al. (2001) Vaccenic acid feeding increases tissue levels of conjugated linoleic acid and suppresses development of premalignant lesions in rat mammary gland. Nutr Cancer 41, 91-97.
30. Corl BA, Barbano DM, Bauman DE, et al. (2003) Cis-9, trans-11 CLA derived endogenously from trans-11 18 : 1 reduces cancer risk in rats. J Nutr 133, 2893-2900.
31. Lock AL, Corl BA, Barbano DM, et al. (2004) The anticarcinogenic effect of trans-11 18 : 1 is dependent on its conversion to cis-9, trans-11 CLA by D9-desaturase in rats. J Nutr 134, 2698-2704.
32. Kuno T, Hirose Y, Yamada Y, et al. (2003) Promoting effects of high-fat corn oil and high-fat mixed lipid diets on 7,12-dimethylbenz[a]anthracene- induced mammary tumorigenesis in F344 rats. Oncol Rep 10, 699-703.
33. Han SN, Leka LS, Lichtenstein AH, et al. (2002) Effect of hydrogenated and saturated, relative to polyunsaturated, fat on immune and inflammatory responses of adults with moderate hypercholesterolemia. J Lipid Res 43, 445-452.
34. Bakker N, Van't VP & Zock PL (1997) Adipose fatty acids and cancers of the breast, prostate and colon: an ecological study. EURAMIC Study Group. Int J Cancer 72, 587-591.
35. Schuurman AG, van den Brandt PA, Dorant E, et al. (1999) Association of energy and fat intake with prostate carcinoma risk: results from The Netherlands Cohort Study. Cancer 86, 1019-1027.
36. Hodge AM, English DR, McCredie MR, et al. (2004) Foods, nutrients and prostate cancer. Cancer Causes Control 15, 11-20.
37. King IB, Kristal AR, Schaffer S, et al. (2005) Serum trans-fatty acids are associated with risk of prostate cancer in b-Carotene and Retinol Efficacy Trial. Cancer Epidemiol Biomarkers Prev 14, 988-992.
38. Xiang Y, Wang Z, Murakami J, et al. (2003) Effects of RNase L mutations associated with prostate cancer on apoptosis induced by 20,50-oligoadenylates. Cancer Res 63, 6795-6801.
39. Roynette CE, Calder PC, Dupertuis YM, et al. (2004) n-3 Polyunsaturated fatty acids and colon cancer prevention. Clin Nutr 23, 139-151.
40. McKelvey W, Greenland S & Sandler RS (2000) A second look at the relation between colorectal adenomas and consumption of foods containing partially hydrogenated oils. Epidemiology 11, 469-473.
41. Slattery ML, Benson J, Ma KN, et al. (2001) Trans-fatty acids and colon cancer. Nutr Cancer 39, 170-175.
42. Theodoratou E, McNeill G, Cetnarskyj R, et al. (2007) Dietary fatty acids and colorectal cancer: a case-control study. Am J Epidemiol 166, 181-195.
43. Theodoratou E, Campbell H, Tenesa A, et al. (2008) Modification of the associations between lifestyle, dietary factors and colorectal cancer risk by APC variants. Carcinogenesis 29, 1774-1780.
44. Limburg PJ, Liu-Mares W, Vierkant RA, et al. (2008) Prospective evaluation of trans-fatty acid intake and colorectal cancer risk in the Iowa Women's Health Study. Int J Cancer 123, 2717-2719.
45. Vinikoor LC, Schroeder JC, Millikan RC, et al. (2008) Consumption of trans-fatty acid and its association with colorectal adenomas. Am J Epidemiol 168, 289-297.
46. Mozaffarian D (2006) Trans fatty acids - effects on systemic inflammation and endothelial function. Atheroscler Suppl 7, 29-32.
47. Dionigi G, Bianchi V, Rovera F, et al. (2007) Genetic alteration in hereditary colorectal cancer. Surg Oncol 16, Suppl. 1, S11-S15.
48. Kohlmeier L, Simonsen N, van't Veer P, et al. (1997) Adipose tissue trans fatty acids and breast cancer in the European Community Multicenter Study on Antioxidants, Myocardial Infarction, and Breast Cancer. Cancer Epidemiol Biomarkers Prev 6, 705-710.
49. London SJ, Sacks FM, Stampfer MJ, et al. (1993) Fatty acid composition of the subcutaneous adipose tissue and risk of proliferative benign breast disease and breast cancer. J Natl Cancer Inst 85, 785-793.
50. Petrek JA, Hudgins LC, Ho M, et al. (1997) Fatty acid composition of adipose tissue, an indication of dietary fatty acids, and breast cancer prognosis. J Clin Oncol 15, 1377-1384.
51. Aro A, Mannisto S, Salminen I, et al. (2000) Inverse association between dietary and serum conjugated linoleic acid and risk of breast cancer in postmenopausal women. Nutr Cancer 38, 151-157.
52. Byrne C, Rockett H & Holmes MD (2002) Dietary fat, fat subtypes, and breast cancer risk: lack of an association among postmenopausal women with no history of benign breast disease. Cancer Epidemiol Biomarkers Prev 11, 261-265.
53. Chajès V, Hultén K, Van Kappel AL, et al. (1999) Fatty-acid composition in serum phospholipids and risk of breast cancer: an incident case-control study in Sweden. Int J Cancer 83, 585-590. (Pubitemid 29508033)
54. Chajès V, Thiébaut AC, Rotival M, et al. (2008) Association between serum trans-monounsaturated fatty acids and breast cancer risk in the E3N-EPIC Study. Am J Epidemiol 167, 1312-1320.
55. Pala V, Krogh V, Muti P, et al. (2001) Erythrocyte membrane fatty acids and subsequent breast cancer: a prospective Italian study. J Natl Cancer Inst 93, 1088-1095.
56. Rissanen H, Knekt P, Jarvinen R, et al. (2003) Serum fatty acids and breast cancer incidence. Nutr Cancer 45, 168-175.
57. Saadatian-Elahi M, Toniolo P, Ferrari P, et al. (2002) Serum fatty acids and risk of breast cancer in a nested case-control study of the New York University Women's Health Study. Cancer Epidemiol Biomarkers Prev 11, 1353-1360.
58. Voorrips LE, Brants HA, Kardinaal AF, et al. (2002) Intake of conjugated linoleic acid, fat, and other fatty acids in relation to postmenopausal breast cancer: the Netherlands Cohort Study on Diet and Cancer. Am J Clin Nutr 76, 873-882.
59. Wang J, John EM, Horn-Ross PL, et al. (2008) Dietary fat, cooking fat, and breast cancer risk in a multiethnic population. Nutr Cancer 60, 492-504.
60. Petrek JA, Hudgins LC, Levine B, et al. (1994) Breast cancer risk and fatty acids in the breast and abdominal adipose tissues. J Natl Cancer Inst 86, 53-56.
61. Ackman RG (1998) Correspondence re: L. Kohlmeier et al. Adipose tissue trans fatty acids and breast cancer in the European Community Multicenter Study on Antioxidants, Myocardial Infarction, and Breast Cancer. Cancer Epidemiol. Biomark. Prev., 6:, 705-710, 1997.
62. Cancer Epidemiol Biomarkers Prev 7, 355-356.
63. Holmes MD, Hunter DJ, Colditz GA, et al. (1999) Association of dietary intake of fat and fatty acids with risk of breast cancer. JAMA 281, 914-920.
64. Key TJ, Allen NE, Spencer EA, et al. (2003) Nutrition and breast cancer. Breast 12, 412-416.
65. Terry PD, Terry JB & Rohan TE (2004) Long-chain (n-3) fatty acid intake and risk of cancers of the breast and the prostate: recent epidemiological studies, biological mechanisms, and directions for future research. J Nutr 134, 3412S-3420S.
66. Pariza MW, Ha YL, Benjamin H, et al. (1991) Formation and action of anticarcinogenic fatty acids. Adv Exp Med Biol 289, 269-272.
67. Lock AL, Corl BA, Barbano DM, et al. (2004) The anticarcinogenic effect of trans-11 18 : 1 is dependent on its conversion to cis-9, trans-11 CLA by D9-desaturase in rats. J Nutr 134, 2698-2704.
68. Turpeinen AM, Mutanen M, Aro A, et al. (2002) Bioconversion of vaccenic acid to conjugated linoleic acid in humans. Am J Clin Nutr 76, 504-510.
69. Warensjo E, Ingelsson E, Lundmark P, et al. (2007) Polymorphisms in the SCD1 gene: associations with body fat distribution and insulin sensitivity. Obesity (Silver Spring) 15, 1732-1740.
70. Riserus U, Tan GD, Fielding BA, et al. (2005) Rosiglitazone increases indexes of stearoyl-CoA desaturase activity in humans: link to insulin sensitization and the role of dominant- negative mutation in peroxisome proliferator-activated receptor-g. Diabetes 54, 1379-1384.
71. Ma DW (2007) Lipid mediators in membrane rafts are important determinants of human health and disease. Appl Physiol Nutr Metab 32, 341-350.
72. Ibrahim A, Natrajan S & Ghafoorunissa R (2005) Dietary trans-fatty acids alter adipocyte plasma membrane fatty acid composition and insulin sensitivity in rats. Metabolism 54, 240-246. (Pubitemid 40174854)
73. Schley PD, Brindley DN & Field CJ (2007) (n-3) PUFA alter raft lipid composition and decrease epidermal growth factor receptor levels in lipid rafts of human breast cancer cells. J Nutr 137, 548-553.
74. Bjorkbom A, Ramstedt B & Slotte JP (2007) Phosphatidylcholine and sphingomyelin containing an elaidoyl fatty acid can form cholesterol-rich lateral domains in bilayer membranes. Biochim Biophys Acta 1768, 1839-1847.
75. Saravanan N, Haseeb A, Ehtesham NZ, et al. (2005) Differential effects of dietary saturated and trans-fatty acids on expression of genes associated with insulin sensitivity in rat adipose tissue. Eur J Endocrinol 153, 159-165.
76. Colomer R, Moreno-Nogueira JM, Garcia-Luna PP, et al. (2007) n-3 Fatty acids, cancer and cachexia: a systematic review of the literature. Br J Nutr 97, 823-831.
77. Stillwell W, Shaikh SR, Zerouga M, et al. (2005) Docosahexaenoic acid affects cell signaling by altering lipid rafts. Reprod Nutr Dev 45, 559-579.
78. Morrow JD, Awad JA, Boss HJ, et al. (1992) Non-cyclooxygenase- derived prostanoids (F2-isoprostanes) are formed in situ on phospholipids. Proc Natl Acad Sci U S A 89, 10721-10725.
79. Clandinin MT, Cheema S, Field CJ, et al. (1991) Dietary fat: exogenous determination of membrane structure and cell function. FASEB J 5, 2761-2769.
80. Kummerow FA, Zhou Q & Mahfouz MM (1999) Effect of trans fatty acids on calcium influx into human arterial endothelial cells. Am J Clin Nutr 70, 832-838.
81. Valko M, Leibfritz D, Moncol J, et al. (2007) Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 39, 44-84.
82. Fleshner N, Bagnell PS, Klotz L, et al. (2004) Dietary fat and prostate cancer. J Urol 171, S19-S24.
83. Rao AV, Fleshner N & Agarwal S (1999) Serum and tissue lycopene and biomarkers of oxidation in prostate cancer patients: a case-control study. Nutr Cancer 33, 159-164.
84. Klaunig JE & Kamendulis LM (2004) The role of oxidative stress in carcinogenesis. Annu Rev Pharmacol Toxicol 44, 239-267.
85. Basu S (2004) Isoprostanes: novel bioactive products of lipid peroxidation. Free Radic Res 38, 105-122.
86. Kuhnt K, Wagner A, Kraft J, et al. (2006) Dietary supplementation with 11trans- and 12trans-18 : 1 and oxidative stress in humans. Am J Clin Nutr 84, 981-988.
87. Tomey KM, Sowers MR, Li X, et al. (2007) Dietary fat subgroups, zinc, and vegetable components are related to urine F2a-isoprostane concentration, a measure of oxidative stress, in midlife women. J Nutr 137, 2412-2419.
88. Zambonin L, Prata C, Cabrini L, et al. (2008) Effect of radical stress and ageing on the occurrence of trans fatty acids in rats fed a trans-free diet. Free Radic Biol Med 44, 594-601.
89. Ferreri C, Panagiotaki M & Chatgilialoglu C (2007) Trans fatty acids in membranes: the free radical path. Mol Biotechnol 37, 19-25.
90. Chatgilialoglu C & Ferreri C (2005) Trans lipids: the free radical path. Acc Chem Res 38, 441-448.
91. Aggarwal BB, Shishodia S, Sandur SK, et al. (2006) Inflammation and cancer: how hot is the link? Biochem Pharmacol 72, 1605-1621.
92. Mozaffarian D, Pischon T, Hankinson SE, et al. (2004) Dietary intake of trans fatty acids and systemic inflammation in women. Am J Clin Nutr 79, 606-612. (Pubitemid 41103904)
93. Bastard JP, Maachi M, Lagathu C, et al. (2006) Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw 17, 4-12.
94. Lopez-Garcia E, Schulze MB, Meigs JB, et al. (2005) Consumption of trans fatty acids is related to plasma biomarkers of inflammation and endothelial dysfunction. J Nutr 135, 562-566.
95. Baer DJ, Judd JT, Clevidence BA, et al. (2004) Dietary fatty acids affect plasma markers of inflammation in healthy men fed controlled diets: a randomized crossover study. Am J Clin Nutr 79, 969-973.
96. Mozaffarian D, Rimm EB, King IB, et al. (2004) Trans fatty acids and systemic inflammation in heart failure. Am J Clin Nutr 80, 1521-1525. (Pubitemid 41103848)
97. Harvey KA, Arnold T, Rasool T, et al. (2008) Trans-fatty acids induce pro-inflammatory responses and endothelial cell dysfunction. Br J Nutr 99, 723-731.
98. Innis SM, Green TJ & Halsey TK (1999) Variability in the trans fatty acid content of foods within a food category: implications for estimation of dietary trans fatty acid intakes. J Am Coll Nutr 18, 255-260.
99. Lemaitre RN, King IB, Patterson RE, et al. (1998) Assessment of trans-fatty acid intake with a food frequency questionnaire and validation with adipose tissue levels of trans-fatty acids. Am J Epidemiol 148, 1085-1093.
100. Stender S, Dyerberg J & Astrup A (2006) High levels of industrially produced trans fat in popular fast foods. N Engl J Med 354, 1650-1652.
101. Morales MS, Palmquist DL & Weiss WP (2000) Effects of fat source and copper on unsaturation of blood and milk triacylglycerol fatty acids in Holstein and Jersey cows. J Dairy Sci 83, 2105-2111.
102. Noci F, Monahan FJ, Scollan ND, et al. (2007) The fatty acid composition of muscle and adipose tissue of steers offered unwilted or wilted grass silage supplemented with sunflower oil and fishoil. Br J Nutr 97, 502-513.
103. Hodson L, Skeaff CM & Fielding BA (2008) Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake. Prog Lipid Res 47, 348-380.
104. Hill RJ & Davies PS (2001) The validity of self-reported energy intake as determined using the doubly labelled water technique. Br J Nutr 85, 415-430.
105. Baylin A, Kabagambe EK, Siles X, et al. (2002) Adipose tissue biomarkers of fatty acid intake. Am J Clin Nutr 76, 750-757.
106. Correa Lima MP & Gomes-da-Silva MH (2005) Colorectal cancer: lifestyle and dietary factors. Nutr Hosp 20, 235-241.
107. Dagnelie PC, Schuurman AG, Goldbohm RA, et al. (2004) Diet, anthropometric measures and prostate cancer risk: a review of prospective cohort and intervention studies. BJU Int 93, 1139-1150.
108. Michels KB, Mohllajee AP, Roset-Bahmanyar E, et al. (2007) Diet and breast cancer: a review of the prospective observational studies. Cancer 109, 2712-2749.
109. Sonn GA, Aronson W & Litwin MS (2005) Impact of diet on prostate cancer: a review. Prostate Cancer Prostatic Dis 8, 304-310.
110. Lampen A, Leifheit M, Voss J, et al. (2005) Molecular and cellular effects of cis-9, trans-11-conjugated linoleic acid in enterocytes: effects on proliferation, differentiation, and gene expression. Biochim Biophys Acta 1735, 30-40.
111. Eitsuka T, Nakagawa K, Suzuki T, et al. (2005) Polyunsaturated fatty acids inhibit telomerase activity in DLD-1 human colorectal adenocarcinoma cells: a dual mechanism approach. Biochim Biophys Acta 1737, 1-10.
112. Awad AB, Herrmann T, Fink CS, et al. (1995) 18 : 1 n 7 Fatty acids inhibit growth and decrease inositol phosphate release in HT-29 cells compared to n 9 fatty acids. Cancer Lett 91, 55-61.